The immunometabolic role of pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis in cardiovascular disease and beyond
Cardiovascular Research · 26.06.2026 · 122 (9) · 1133-1142
DOI: 10.1093/cvr/cvag088 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 23.04.2026. Verfasst von Andrietta Grentzmann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular and Renal Research Unit, Department of Molecular Medicine, University of Southern Denmark, Campusvej 55, Odense M DK 5230, Denmark. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Energy Metabolism, Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Pyruvate Dehydrogenase Complex. Die Arbeit nennt 117 Literaturangaben. Gefördert von: Novo Nordisk Foundation, Independent Research Fund Denmark, Simon Fougner Hartmanns Familiefond.
Abstract (Originalsprache)
The pyruvate dehydrogenase kinase (PDK)/pyruvate dehydrogenase (PDH) axis plays a pivotal role in regulating cellular energy metabolism, controlling the flux between the tricarboxylic acid cycle and oxidative phosphorylation. Traditionally viewed through a metabolic lens, this axis is now emerging as a crucial regulator of immune cell function, placing it at the intersection of metabolism and immunity and underscoring its central role in immunometabolism. In this review, we highlight the multifaceted roles of the PDK/PDH axis in orchestrating metabolic reprogramming and immune cell plasticity, highlighting its broader significance across several pathological conditions. Thus, we emphasize the role of this axis in cardiometabolic disease, where its regulation has been shown to highly impact immune and vascular cell functions and to modulate disease progression. Given the promising results from clinical studies beyond the cardiovascular field and from preclinical models of cardiovascular disease, we discuss insights from metabolic reprogramming that may guide therapeutic strategies targeting the immunometabolic dysfunction driving vascular inflammation and its deleterious consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular and Renal Research Unit, Department of Molecular Medicine, University of Southern Denmark, Campusvej 55, Odense M DK 5230, Denmark.
ORCID-Profile: Andrietta Grentzmann, Daniel F J Ketelhuth
Förderung
- Novo Nordisk Foundation
- Independent Research Fund Denmark
- Simon Fougner Hartmanns Familiefond
- University of Southern Denmark
- European Union's Horizon Europe Research and Innovation Framework
- Danish Cardiovascular Academy
- The Danish Heart Foundation
- European Union’s Horizon Europe Research and Innovation Framework
Zitieren
APA
Grentzmann, A., & Ketelhuth, D. F. J. (2026). The immunometabolic role of pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis in cardiovascular disease and beyond. Cardiovascular Research, 122(9), 1133-1142. https://doi.org/10.1093/cvr/cvag088
Vancouver
Grentzmann A, Ketelhuth DFJ. The immunometabolic role of pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis in cardiovascular disease and beyond. Cardiovascular Research. 2026;122(9):1133-1142. doi:10.1093/cvr/cvag088
BibTeX
@article{Grentzmann2026,
author = {Grentzmann, Andrietta and Ketelhuth, Daniel F J},
title = {The immunometabolic role of pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis in cardiovascular disease and beyond},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {9},
pages = {1133--1142},
doi = {10.1093/cvr/cvag088}
}
EUVIMED